Toggle navigation
Home
Search
Services
Blog
Contact
About
Preventing Retinal Neovascularization with Nrts
Narducy, Kenneth W.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 16 grants from Kenneth Narducy
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Sleep, Energetic Behaviors, and Adolescent Obesity during the Transition from Middle to High School
Natl,Non-Profit Ph Prof. Org.with with A Large &Broad-Based Membership
Effects of Aging on Thermic Effect of Feeding
Elicitation of Protective Immunity to Chlamydia Trachomatis by DNA Vaccination
SGER: Conference on Attributional Processes and Perception, Princeton, New Jersey, March 23-25,1995
Recently added grants:
SimTK: An Ecosystem for Data and Model Sharing in the Biomechanics Community
Role of Tet proteins in epigenetic regulation of embryonic stem cell biology
Analysis tools for quantifying protein conformational landscapes using DEER spectroscopy
Chelator development for improved scandium theranostic agents
eIF2A in translational control
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011061-01A1
Application #
2165317
Study Section
Special Emphasis Panel (ZRG1-VISA (01))
Project Start
1996-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Comments
Be the first to comment on Kenneth Narducy's grant